These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25970949)

  • 1. Diabetes mellitus, chronic complication in patients with acromegaly: case report and review of the literature.
    Galesanu C; Buzduga C; Florescu A; Moisii L; Ciubotaru V
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):92-6. PubMed ID: 25970949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.
    Oscarsson J; Wiklund O; Jakobsson KE; Petruson B; Bengtsson BA
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):603-8. PubMed ID: 7828349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
    Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic profile in patients with acromegaly treated with somatostatin analogue.
    Valea A; Carsote M; Ghervan C; Georgescu C
    J Med Life; 2015; 8 Spec Issue(Spec Issue):82-6. PubMed ID: 26361517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute.
    Yoshida N; Goto H; Suzuki H; Nagasawa K; Takeshita A; Okubo M; Miyakawa M; Mori Y; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Eur J Endocrinol; 2013 Jul; 169(1):127-32. PubMed ID: 23828957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
    Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
    Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report.
    Iwai H; Ito H; Ri S; Harada T; Hirota N; Yamauchi T; Miyatake T; Ohno Y; Aoki N
    Endocr J; 2005 Aug; 52(4):413-20. PubMed ID: 16127208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concurrent diabetes on periodontal health in patients with acromegaly.
    Jain A; Gupta S; Bhansali A; Gupta M; Jain A; Bhaskar N; Kaur RK
    Sci Rep; 2020 Nov; 10(1):19170. PubMed ID: 33154456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of acromegaly in a patient with type 1 diabetes mellitus.
    Hofmann EA; Polonsky KS; Weiss RE
    Endocr Pract; 2002; 8(2):113-8. PubMed ID: 11942776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of 6 Months' Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings.
    Witek P; Bolanowski M; Szamotulska K; Wojciechowska-Luźniak A; Jawiarczyk-Przybyłowska A; Kałużny M
    Front Endocrinol (Lausanne); 2021; 12():633944. PubMed ID: 33776927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIDDM: new once-daily intervention for type 2 diabetes mellitus: Diaprel MR.
    Ionescu-Tîrgovişte C; Gavrilă L; Brădescu OM; Guja C
    Rom J Intern Med; 2004; 42(2):431-40. PubMed ID: 15529633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe cardiovascular complications due to the pituitary adenoma with acromegaly. An interdisciplinary approach to the treatment. A case report].
    Zieliński G; Hendzel P; Szałański P; Gołowicz J; Gryszko L; Podgórski JK
    Neurol Neurochir Pol; 2006; 40(4):354-60. PubMed ID: 16967359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acromegaly].
    Chanson P
    Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.